Mapping heart cell health with a new imaging tracer
This study tests a new imaging tracer called 18F-TPP to map the electrical health of heart cells. It may help researchers better understand heart conditions in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health, with no known heart disease.
- You must be willing to undergo an MRI and PET scan.
- You cannot have any metal implants or devices in your body that are not safe for MRI.
- You must not be pregnant or breastfeeding.
- You must not have had recent radiation exposure from work or other studies that would exceed safety limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new radioactive dye called [18F]GATT-44 to see how well it can show a specific brain protein on a PET scan. It may help researchers better understand brain conditions in the future.
This study uses a new imaging technique (PET scan with a tracer called evuzamitide) to detect a type of heart disease called cardiac amyloidosis in patients whose standard heart scans were unclear but who have elevated levels of a new blood marker (TAD1). The goal is to find a better way to diagnose this condition.
This Phase 1 study tests whether a specialized heart MRI injection can show how the heart uses energy. It may help researchers better understand heart muscle thickening and related conditions, and identify heart-related changes early.
This study uses a special imaging test (PET/MR) to check if damaged heart muscle is still alive and can recover. It is for people with severe blocked arteries and weak heart pumping function who are planning bypass surgery or stem cell treatment.
This study evaluates a new way to analyze heart function using a standard cardiac MRI scanner. If you have heart disease and need a heart MRI anyway, this trial tests whether this new analysis method works well across different hospitals and MRI machines.
This study tests a new MRI method that uses a safe, natural substance (pyruvate) to take detailed pictures of the heart and metabolism. It may help doctors better understand heart disease, diabetes, and related conditions.
Hear when a new Membrane Potential Mapping trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.